|
Volumn 291, Issue 1, 2004, Pages 62-69
|
Gene doping
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIBODIES;
BIOPSY;
BONE;
DOPING (ADDITIVES);
DRUG PRODUCTS;
MATHEMATICAL MODELS;
MUSCLE;
PATIENT TREATMENT;
PROTEINS;
TISSUE;
TUMORS;
VIRUSES;
DIGESTIVE TRACTS;
FIBROUS TISSUES;
MUSCULAR DYSTROPHYS;
MYOFIBRILS;
GENES;
SYNTHETIC CONSTRUCT;
DYSTROPHIN;
ERYTHROPOIETIN;
MYOSTATIN;
SOMATOMEDIN C;
TRANSFORMING GROWTH FACTOR BETA;
AGING;
ANIMAL;
ARTICLE;
CATTLE;
DOG;
DOPING;
ENERGY METABOLISM;
GENE THERAPY;
GENE VECTOR;
GENETIC TRANSFECTION;
GENETICS;
HISTOLOGY;
HUMAN;
MALE;
MOUSE;
MUSCLE CONTRACTION;
MUSCLE FIBRIL;
MUSCLE WEAKNESS;
MUSCULAR DYSTROPHY;
PHYSIOLOGY;
RAT;
REGENERATION;
SKELETAL MUSCLE;
SPORT;
AGING;
ANIMALS;
CATTLE;
DOGS;
DOPING IN SPORTS;
DYSTROPHIN;
ENERGY METABOLISM;
ERYTHROPOIETIN;
GENE THERAPY;
GENETIC VECTORS;
HUMANS;
INSULIN-LIKE GROWTH FACTOR I;
MALE;
MICE;
MUSCLE CONTRACTION;
MUSCLE WEAKNESS;
MUSCLE, SKELETAL;
MUSCULAR DYSTROPHIES;
MYOFIBRILS;
RATS;
REGENERATION;
SPORTS;
TRANSFECTION;
TRANSFORMING GROWTH FACTOR BETA;
|
EID: 3142558011
PISSN: 00368733
EISSN: None
Source Type: Journal
DOI: 10.1038/scientificamerican0704-62 Document Type: Review |
Times cited : (53)
|
References (0)
|